Phospholemman: A novel cardiac stress protein

Clinical and Translational Science

Volumn 3, Issue 4, 2010, Pages 189-196

  Cheung, Joseph Y ^a   Zhang, Xue Qian ^a   Song, Jianliang ^a   Gao, Erhe ^a   Rabinowitz, Joseph E ^a   Chan, Tung O ^a   Wang, JuFang ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Ion transport regulator; Phospholemman; Protein kinase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CATECHOLAMINE; CELL PROTEIN; PROTEIN PHOSPHOLEMMAN; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION; UNCLASSIFIED DRUG;

AGING; ARRHYTHMOGENESIS; CARDIOVASCULAR RISK; EXERCISE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HETEROLOGOUS EXPRESSION; HOMEOSTASIS; HUMAN; IMMUNOPRECIPITATION; ION TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; HEART; HEART FAILURE; HUMANS; MEMBRANE PROTEINS; PHOSPHOPROTEINS; SARCOLEMMA; STRESS, PHYSIOLOGICAL;

EID: 77955752570     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2010.00213.x     Document Type: Review

References (92)

1. Presti CF, Jones LR, Lindemann JP. Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J Biol Chem 1985, 260:3860-3867.
2. Presti CF, Scott BT, Jones LR. Identification of an endogenous protein kinase C activity and its intrinsic 15-kilodalton substrate in purified canine cardiac sarcolemmal vesicles. J Biol Chem 1985, 260:13879-13889.
3. Lindemann JP. α-adrenergic stimulation of sarcolemmal protein phosphorylation and slow responses in intact myocardium. J Biol Chem 1986, 261:4860-4867.
4. Palmer CJ, Scott BT, Jones LR. Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 1991, 266:11126-11130.
5. Chen LS, Lo CF, Numann R, Cuddy M. Characterization of the human and rat phospholemman (PLM) cDNAs and localization of the human PLM gene to chromosome 19q13.1. Genomics 1997, 41:435-443.
6. Simmerman HK, Jones LR. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 1998, 78:921-947.
7. Waalas SI, Czernik AJ, Olstad OK, Sletten K, Walaas O. Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenaline-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain. Biochem J 1994, 304:635-640.
8. Franzin CM, Gong XM, Thai K, Yu J, Marassi FM. NMR of membrane proteins in micelles and bilayers: the FXYD family proteins. Methods (San Diego, Calif) 2007, 41:398-408.
9. Beevers AJ, Kukol A. Secondary structure, orientation, and oligomerization of phospholemman, a cardiac transmembrane protein. Protein Sci 2006, 15:1127-1132.
10. Teriete P, Franzin CM, Choi J, Marassi FM. Structure of the Na,K-ATPase regulatory protein FXYD1 in micelles. Biochemistry 2007, 46:6774-6783.
11. Fuller W, Howie J, McLatchie L, Weber R, Hastie CJ, Burness K, Pavlovic D, Shattock MJ. FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol 2009, 296:C1346-C1355.
12. Song J, Zhang XQ, Ahlers BA, Carl LL, Wang J, Rothblum LI, Stahl RC, Mounsey JP, Tucker AL, Moorman JR, Cheung JY. Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2005, 288:H2342-H2354.
13. Rembold CM, Ripley ML, Meeks MK, Geddis LM, Kutchai HC, Marassi FM, Cheung JY, Moorman JR. Serine 68 phospholemman phosphorylation during forskolin-induced swine carotid artery relaxation. J Vasc Res 2005, 42:483-491.
14. Zhang XQ, Moorman JR, Ahlers BA, Carl LL, Lake DE, Song J, Mounsey JP, Tucker AL, Chan YM, Rothblum LI, Stahl RC, Carey DJ, Cheung JY. Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in post-infarction myocytes. J Appl Physiol 2006, 100:212-220.
15. Silverman BZ, Fuller W, Eaton P, Deng J, Moorman JR, Cheung JY, James AF, Shattock MJ. Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase. Cardiovasc Res 2005, 65:93-103.
16. Zhang XQ, Wang J, Carl LL, Song J, Ahlers BA, Cheung JY. Phospholemman regulates cardiac Na+/Ca2+ exchanger by interacting with the exchanger's proximal linker domain. Am J Physiol Cell Physiol 2009, 296:C911-C921.
17. Moorman JR, Ackerman SJ, Kowdley GC, Griffin M, Mounsey JP, Chen Z, Cala SE, O'Brian JJ, Szabo G, Jones LR. Unitary anion currents through phospholemman channel molecules. Nature 1995, 377:737-740.
18. Chen Z, Jones LR, O'Brian JJ, Moorman JR, Cala SE. Structural domains in phospholemman: a possible role for the carboxyl terminus in channel inactivation. Circ Res 1998, 82:367-374.
19. Davis CE, Patel MK, Miller JR, John JE, Jones LR, Tucker AL, Mounsey JP, Moorman JR. Effects of phospholemman expression on swelling-activated ion currents and volume regulation in embryonic kidney cells. Neurochem Res 2004, 29:177-187.
20. Morales-Mulia M, Pasantes-Morales H, Moran J. Volume sensitive efflux of taurine in HEK 293 cells overexpressing phospholemman. Biochem Biophys Acta 2000, 1496:252-260.
21. Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 2000, 68:41-56.
22. Mounsey JP, John J, Helmke S, Bush E, Gilbert J, Roses A, Perryman M, Jones LR, Moorman JR. Phospholemman is a substrate for myotonic dystrophy protein kinase. J Biol Chem 2000, 275:23362-23367.
23. Crambert G, Fuzesi M, Garty H, Karlish S, Geering K. Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties. Proc Natl Acad Sci U S A 2002, 99:11476-11481.
24. Bossuyt J, Despa S, Han F, Hou Z, Robia SL, Lingrel JB, Bers DM. Isoform-specificity of the Na/K-ATPase association and regulation by phospholemman. J Biol Chem 2009, 284:26749-26757.
25. Despa S, Bossuyt J, Han F, Ginsburg KS, Jia LG, Kutchai H, Tucker AL, Bers DM. Phospholemman-phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 2005, 97:252-259.
26. Han F, Tucker AL, Lingrel JB, Despa S, Bers DM. Extracellular potassium dependence of the Na+-K+-ATPase in cardiac myocytes: isoform specificity and effect of phospholemman. Am J Physiol Cell Physiol 2009, 297:C699-C705.
27. Bell JR, Kennington E, Fuller W, Dighe K, Donoghue P, Clark JE, Jia LG, Tucker AL, Moorman JR, Marber MS, Eaton P, Dunn MJ, Shattock MJ. Characterisation of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na/K ATPase activity. Am J Physiol 2008, 294:H613-H621.
28. Fuller W, Eaton P, Bell JR, Shattock MJ. Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J 2004, 18:197-199.
29. Han F, Bossuyt J, Despa S, Tucker AL, Bers DM. Phospholemman phosphorylation mediates the protein kinase C-dependent effects on Na+-K+ pump function in cardiac myocytes. Circ Res 2006, 99:1376-1383.
30. Pavlovic D, Fuller W, Shattock MJ. The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase. FASEB J 2007, 21:1539-1546.
31. Song J, Zhang XQ, Wang J, Cheskis E, Chan TO, Feldman AM, Tucker AL, Cheung JY. Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchanger versus Na+-K+-ATPase. Am J Physiol Heart Circ Physiol 2008, 295:H1615-H1625.
32. Wang J, Gao E, Song J, Zhang XQ, Li J, Koch WJ, Tucker AL, Philipson KD, Chan TO, Feldman AM, Cheung JY. Phospholemman and β-adrenergic stimulation in the heart. Am J Physiol Heart Circ Physiol 2010, 298:H807-H815.
33. Li C, Grosdidier A, Crambert G, Horisberger JD, Michielin O, Geering K. Structural and functional interaction sites between Na,K-ATPase and FXYD proteins. J Biol Chem 2004, 279:38895-38902.
34. Lindzen M, Gottschalk KE, Fuzesi M, Garty H, Karlish SJ. Structural interactions between FXYD proteins and Na+-K+-ATPase: α/β/FXYD subunit stoichiometry and cross-linking. J Biol Chem 2006, 281:5947-5955.
35. Shinoda T, Ogawa H, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature 2009, 459:446-450.
36. Mahmmoud YA, Vorum H, Cornelius F. Purification of a phospholemman-like protein from shark rectal glands. J Biol Chem 2000, 275:35969-35977.
37. Teriete P, Thai K, Choi J, Marassi FM. Effects of PKA phosphorylation on the conformation of the Na,K-ATPase regulatory protein FXYD1. Biochim Biophys Acta 2009, 1788:2462-2470.
38. Bossuyt J, Despa S, Martin JL, Bers DM. Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump. J Biol Chem 2006, 281:32765-32773.
39. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 1998, 275:F633-F650.
40. McDonough A, Zhang Y, Shin V, Frank JS. Subcellular distribution of sodium pump isoform subunits in mammalian cardiac myocytes. Am J Physiol Cell Physiol 1996, 270:C1221-C1227.
41. Zahler R, Gilmore-Hebert M, Baldwin JC, Franco K, Benz EJ. Expression of alpha isoforms of the Na,K-ATPase in human heart. Biochim Biophys Acta 1993, 1149:189-194.
42. Bossuyt J, Ai X, Moorman JR, Pogwizd SM, Bers DM. Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure. Circ Res 2005, 97:558-565.
43. Berry RG, Despa S, Fuller W, Bers DM, Shattock MJ. Differential distribution and regulation of mouse cardiac Na+-K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc Res 2007, 73:92-100.
44. Sweadner KJ, Herrera V, Amato S, Moellmann A, Gibbons D, Repke K. Immunologic identification of Na+, K+-ATPase isoforms in myocardium. Circ Res 1994, 74:669-678.
45. Swift F, Tovsrud N, Enger UH, Sjaastad I, Sejersted OM. The Na+-K+-ATPase α2-isoform regulates cardiac contractility in rat cardiomyocytes. Cardiovasc Res 2007, 75:109-117.
46. Dostanic I, Schultz Jel J, Lorenz JN, Lingrel JB. The alpha 1 isoform of Na,K-ATPase regulates cardiac contractility and functionally interacts and co-localizes with the Na/Ca exchanger in heart. J Biol Chem 2004, 279:54053-54061.
47. Bibert S, Roy S, Schaer D, Horisberger JD, Geering K. Phosphorylation of phospholemman (FXYD1) by protein kinases A and C modulates distinct Na,K-ATPase isozymes. J Biol Chem 2008, 283:476-486.
48. Bers DM. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
49. Grupp I, Im WB, Lee C, Lee SW, Pecker M, Schwartz A. Regulation of sodium pump inhibition to positive inotrophy at low concentrations of ouabain in rat heart muscle. J Physiol (Lond) 1985, 360:149-160.
50. Song J, Zhang XQ, Carl LL, Qureshi A, Rothblum LI, Cheung JY. Overexpression of phospholemman alter contractility and [Ca2+]i transients in adult rat myocytes. Am J Physiol Heart Circ Physiol 2002, 283:H576-H583.
51. Zhang XQ, Qureshi A, Song J, Carl LL, Tian Q, Stahl RC, Carey DJ, Rothblum LI, Cheung JY. Phospholemman modulates Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2003, 284:H225-H233.
52. Tadros GM, Zhang XQ, Song J, Carl LL, Rothblum LI, Tian Q, Dunn J, Lytton J, Cheung JY. Effects of Na+/Ca2+ exchanger downregulation on contractility and [Ca2+]i transients in adult rat myocytes. Am J Physiol Heart Circ Physiol 2002, 283:H1616-H1626.
53. Zhang XQ, Song J, Rothblum LI, Lun M, Wang X, Ding F, Dunn J, Lytton J, McDermott PJ, Cheung JY. Overexpression of Na+/Ca2+ exchanger alters contractility and SR Ca2+ content in adult rat myocytes. Am J Physiol Heart Circ Physiol 2001, 281:H2079-H2088.
54. Ahlers BA, Zhang XQ, Moorman JR, Rothblum LI, Carl LL, Song J, Wang J, Geddis LM, Tucker AL, Mounsey JP, Cheung JY. Identification of an endogenous inhibitor of the cardiac Na+/Ca2+ exchanger, phospholemman. J Biol Chem 2005, 280:19875-19882.
55. Mirza MA, Zhang XQ, Ahlers BA, Qureshi A, Carl LL, Song J, Tucker AL, Mounsey JP, Moorman JR, Rothblum LI, Zhang TS, Cheung JY. Effects of phospholemman downregulation on contractility and [Ca2+]i transients in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 2004, 286:H1322-H1330.
56. Wang X, Gao G, Guo K, Yarotskyy V, Huang C, Elmslie KS, Peterson BZ. Phospholemman modulates the gating of cardiac L-type calcium channels. Biophys J 2010, 98:1149-1159.
57. Zhang XQ, Ahlers BA, Tucker AL, Song J, Wang J, Moorman JR, Mounsey JP, Carl LL, Rothblum LI, Cheung JY. Phospholemman inhibition of the cardiac Na+/Ca2+ exchanger. Role of phosphorylation. J Biol Chem 2006, 281:7784-7792.
58. Tucker AL, Song J, Zhang XQ, Wang J, Ahlers BA, Carl LL, Mounsey JP, Moorman JR, Rothblum LI, Cheung JY. Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange. Am J Physiol Heart Circ Physiol 2006, 291:H2199-H2209.
59. Cheung JY, Rothblum LI, Moorman JR, Tucker AL, Song J, Ahlers BA, Carl LL, Wang J, Zhang XQ. Regulation of cardiac Na+/Ca2+ exchanger by phospholemman. Ann NY Acad Sci 2007, 1099:119-134.
60. Nicoll DA, Ottolia M, Lu L, Lu Y, Philipson KD. A new topological model of the cardiac sarcolemmal Na+/Ca2+ exchanger. J Biol Chem 1999, 274:910-917.
61. Philipson KD, Nicoll DA. Sodium-calcium exchange: a molecular perspective. Annu Rev Physiol 2000, 62:111-133.
62. Iwamoto T, Uehara A, Imanaga I, Shigekawa M. The Na+/Ca2+ exchanger NCX1 has oppositely oriented reentrant loop domains that contain conserved aspartic acids whose mutation alters its apparent Ca2+ affinity. J Biol Chem 2000, 275:38571-38580.
63. Nicoll DA, Hryshko LV, Matsuoka S, Frank JS, Philipson KD. Mutation of amino acid residues in the putative transmembrane segments of the cardiac sarcolemmal Na+/Ca2+ exchanger. J Biol Chem 1996, 271:13385-13391.
64. Levitsky DO, Nicoll DA, Philipson KD. Identification of the high affinity Ca2+-binding domain of the cardiac Na+/Ca2+ exchanger. J Biol Chem 1994, 269:22847-22852.
65. Li Z, Nicoll DA, Collins A, Hilgemann D, Filoteo A, Penniston J, Weiss J, Tomich J, Philipson KD. Identification of a peptide inhibitor of the cardiac sarcolemmal Na+-Ca2+ exchanger. J Biol Chem 1991, 266:1014-1020.
66. Maack C, Ganesan A, Sidor A, O'Rourke B. Cardiac sodium-calcium exchanger is regulated by allosteric calcium and exchanger inhibitory peptide at distinct sites. Circ Res 2005, 96:91-99.
67. Wang J, Zhang XQ, Ahlers BA, Carl LL, Song J, Rothblum LI, Stahl RC, Carey DJ, Cheung JY. Cytoplasmic tail of phospholemman interacts with the intracellular loop of the cardiac Na+/Ca2+ exchanger. J Biol Chem 2006, 281:32004-32014.
68. Reuter H. The dependence of slow inward current in Purkinje fibres on the extracellular calcium-concentration. J Physiol 1967, 192:479-492.
69. Zhang XQ, Moore RL, Tillotson DL, Cheung JY. Calcium currents in postinfarction rat cardiac myocytes. Am J Physiol 1995, 269:C1464-C1473.
70. Lemke T, Welling A, Christel CJ, Blaich A, Bernhard D, Lenhardt P, Hofmann F, Moosmang S. Unchanged β-adrenergic stimulation of cardiac L-type calcium channels in Cav1.2 phosphorylation site S1928A mutant mice. J Biol Chem 2008, 283:34738-34744.
71. Despa S, Tucker AL, Bers DM. PLM-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during β-adrenergic stimulation in mouse ventricular myocytes. Circulation 2008, 117:1849-1855.
72. Jia LG, Donnet C, Bogaev RC, Blatt RJ, McKinney CE, Day KH, Berr SS, Jones LR, Moorman JR, Sweadner KJ, Tucker AL. Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice. Am J Physiol Heart Circ Physiol 2005, 288:H1982-H1988.
73. Srivastava S, Cala SE, Coetzee WA, Artman M. Phospholemman expression is high in the newborn rabbit heart and declines with postnatal maturation. Biochem Biophys Res Comm 2007, 355:338-341.
74. Reis J, Zhang L, Cala S, Jew KN, Mace LC, Chung L, Moore RL, Ng YC. Expression of phospholemman and its association with Na+-K+-ATPase in skeletal muscle: effects of aging and exercise training. J Appl Physiol 2005, 99:1508-1515.
75. Rasmussen MK, Kristensen M, Juel C. Exercise-induced regulation of phospholemman (FXYD1) in rat skeletal muscle: implications for Na+-K+-ATPase activity. Acta Physiol (Oxford, England) 2008, 194:67-79.
76. Sehl PD, Tai JT, Hillan KJ, Brown LA, Goddard A, Yang R, Jin H, Lowe DG. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 2000, 101:1990-1999.
77. Dixon I, Hata T, Dhalla N. Sarcolemmal Na+-K+-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol Cell Physiol 1992, 262:C664-C671.
78. Dixon I, Hata T, Dhalla N. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol Heart Circ Physiol 1992, 262:H1387-H1394.
79. Zhang XQ, Tillotson DL, Moore RL, Zelis R, Cheung JY. Na+/Ca2+ exchange currents and SR Ca2+ contents in postinfarction myocytes. Am J Physiol 1996, 271:C1800-C1807.
80. Madhani M, Hall AR, Cuello F, Charles RL, Burgoyne JR, Fuller W, Hobbs AJ, Shattock MJ, Eaton P. Phospholemman Ser-69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury. Am J Physiol Heart Circ Physiol 2010
81. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ Res 2001, 88:1159-1167.
82. Parrillo JE. Pathogenetic mechanisms of septic shock. New Eng J Med 1993, 328:1471-1477.
83. Grocott-Mason RM, Shah AM. Cardiac dysfunction in sepsis: new theories and clinical implications. Intensive Care Med 1998, 24:286-295.
84. Figtree GA, Liu CC, Bibert S, Hamilton EJ, Garcia A, White CN, Chia KK, Cornelius F, Geering K, Rasmussen HH. Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation. Circ Res 2009, 105:185-193.
85. William M, Vien J, Hamilton E, Garcia A, Bundgaard H, Clarke RJ, Rasmussen HH. The nitric oxide donor sodium nitroprusside stimulates the Na+-K+ pump in isolated rabbit cardiac myocytes. J Physiol 2005, 565:815-825.
86. Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psych 2002, 59:631-640.
87. Naidu S. Rett syndrome: a disorder affecting early brain growth. Ann Neurol 1997, 42:3-10.
88. Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S, Pevsner J, Dissen GA, Sherman LS, Ojeda SR. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 2007, 16:640-650.
89. Jordan C, Li HH, Kwan HC, Francke U. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med. Genet 2007, 8:36.
90. Meij IC, Koenderink JB, van Bokhoven H, Assink KF, Groenestege WT, de Pont JJ, Bindels RJ, Monnens LA, van den Heuvel LP, Knoers NV. Dominant isolated renal magnesium loss is caused by misrouting of the Na+-K+-ATPase ?-subunit. Nat Genet 2000, 26:265-266.
91. Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S. FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues. Biol Pharm Bull 2009, 32:1148-1154.
92. Nam JS, Hirohashi S, Wakefield LM. Dysadherin: a new player in cancer progression. Cancer Lett 2007, 255:161-169.